Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults
Abstract This parallel‐arm, phase I study investigated the potential cytochrome P450 (CYP)3A induction effect of NBI‐1065845 (TAK‐653), an investigational α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor potentiator in phase II development for major depressive disorder. The midazolam tr...
Saved in:
Main Authors: | Swan Lin (Author), Adrian Ionescu (Author), Jessica Maynard‐Scott (Author), Mike Kennedy (Author), David P. Walling (Author), Maura Furey (Author), Jaskaran B. Singh (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
by: Rachel A. Bonnema, et al.
Published: (2011) -
Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers
by: Ganesh Cherala, et al.
Published: (2022) -
Cycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval
by: Nappi RE, et al.
Published: (2017) -
The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 µg/levonorgestrel 100 µg + ethinyl estradiol 10 µg
by: Sheila Krishnan, et al.
Published: (2010) -
New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control
by: Anita Nelson
Published: (2010)